TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head. September 9, 2005
TCL Archive Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala June 18, 1993
TCL Archive In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident April 30, 1976
